Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2017

Open Access 01-12-2017 | Correction

Correction to: Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study

Authors: Norma Sánchez-Zauco, Javier Torres, Alejandro Gómez, Margarita Camorlinga-Ponce, Leopoldo Muñoz-Pérez, Roberto Herrera-Goepfert, Rafael Medrano-Guzmán, Silvia Giono-Cerezo, Carmen Maldonado-Bernal

Published in: BMC Cancer | Issue 1/2017

Login to get access

Excerpt

After publication of the original article [1] the authors found the following author names were incorrect and needed to be amended:
  • In the original article, author Javier Torres’ name was presented as J. Torres.
  • In the original article author Roberto Herrera-Goepfert’s first name was incorrectly presented as Ramón.
…
Literature
1.
Metadata
Title
Correction to: Circulating blood levels of IL-6, IFN-γ, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study
Authors
Norma Sánchez-Zauco
Javier Torres
Alejandro Gómez
Margarita Camorlinga-Ponce
Leopoldo Muñoz-Pérez
Roberto Herrera-Goepfert
Rafael Medrano-Guzmán
Silvia Giono-Cerezo
Carmen Maldonado-Bernal
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2017
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3657-y

Other articles of this Issue 1/2017

BMC Cancer 1/2017 Go to the issue

Research article

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

Case report

Pneumatosis cystoides intestinalis associated with sunitinib and a literature review

Research article

A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients

Research article

A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients

Case report

Vaginal metastasis as the initial presentation of leiomyosarcoma: a case report

Research article

CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits